Results 61 to 70 of about 582,345 (116)

Integrating antibody–drug conjugates into solid tumor oncology: Current standards and future directions

open access: yesCancer, Volume 132, Issue S1, 1 June 2026.
Abstract Antibody–drug conjugates (ADCs) represent a major advance in precision oncology, combining the selectivity of monoclonal antibodies with the cytotoxic potency of chemotherapy. By enabling targeted intracellular delivery of highly potent payloads, ADCs aim to maximize antitumor activity while minimizing systemic toxicity. This review summarizes
André Mansinho   +3 more
wiley   +1 more source

Eosinophilic variant of eccrine porocarcinoma of the scalp: Case report and review of the literature

open access: yesInternational Journal of Women's Dermatology, 2017
Porocarcinoma is a rare malignant neoplasm of the acrosyringium with metastatic potential that most commonly presents on the acral skin in older adults (mean age = 72 years).
M.D. Horwich   +3 more
doaj   +1 more source

Ultrasonographic Features of Spiradenomas and Cylindromas as Diagnostic Clues in the Pre‐Therapeutic Setting

open access: yes
JEADV Clinical Practice, Volume 5, Issue 3, Page 1004-1007, September 2026.
Diana Crisan   +5 more
wiley   +1 more source

Nonmass‐Forming Type Anocanal Cancer With Pagetoid Spread With a Challenging Differential Diagnosis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Pagetoid spread (PS) of anorectal cancer is relatively rare and is associated with poor prognosis compared with Extramammary Paget disease. It is therefore essential to accurately differentiate between the two entities. In PS cases, the primary tumor lesion is usually obvious; however, this is not the case in nonmass‐forming type anorectal ...
Mizunori Yaegashi   +3 more
wiley   +1 more source

Case Report: A challenging diagnosis of an apocrine sweat gland carcinoma

open access: yesFrontiers in Surgery
The differential diagnosis for an axillary mass in a patient with a previously treated malignancy is broad and definitive tissue diagnosis is required to guide treatment and surveillance strategies.
Adeel Ahmad   +5 more
doaj   +1 more source

Adenoid basal cell carcinoma and its mimics

open access: yesIndian Journal of Dermatology, 2013
Basal cell carcinoma (BCC) is the most common malignant tumor of skin. The most common site (80%) is head and neck. BCC exhibits a varied morphology such as adenoid, keratotic, sebaceous, basosquamous, apocrine, eccrine or fibroepithelial.
Sujata Jetley   +3 more
doaj   +1 more source

A Multifaceted Holistic Review of the Literature on Scar Dermatoses

open access: yesInternational Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Many cutaneous diseases originate or manifest in scars. Scars are areas of compromised skin, which renders them a vulnerable cutaneous district for diseases to develop. The pathophysiology explaining why some dermatoses grow in scars is not yet thoroughly explored. The present study reviews the present literature on scar dermatoses.
Dana Maria Khoury   +5 more
wiley   +1 more source

A Case of Syringoid Eccrine Carcinoma Successfully Treated with Mohs Micrographic Surgery [PDF]

open access: yes, 2006
Syringoid eccrine carcinoma is a rare adnexal tumor of eccrine origin, and has metastatic potential and high recurrence rate following conventional surgical excision.
정기양
core  

Microcystic adnexal carcinoma: A focused review and updates

open access: yesJournal of Dermatology and Dermatologic Surgery, 2015
Microcystic adnexal carcinoma (MAC) is an uncommon, locally aggressive, malignant cutaneous tumor with pilar and eccrine differentiation. In this article we describe the clinical presentation, pathologic hallmarks, and the use of new adjunct diagnostic ...
Nouran S. Hamed, Amor Khachemoune
doaj   +1 more source

RNA‐Sequencing Reveals Two Subgroups of Eccrine Porocarcinomas and Poromas

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 8, April 2026.
ABSTRACT Eccrine porocarcinoma (EPC), a rare malignant eccrine gland tumour, remains molecularly understudied. Transcriptomic studies of EPC and benign eccrine poroma (EP) have identified recurrent fusions and expression changes, but differences distinguishing malignant EPC from benign EP are unclear.
Maya Puttonen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy